21Vianet plans to issue 11.5 million American depositary shares (ADSs), each representing six class A ordinary shares, according to its regulatory filing.

Intelect Medical is developing technologies for deep brain stimulation (DBS) therapy and Boston Scientific (BoSci) values the target at $78m.

Two German corporate venturing units, eVenture and T-Venture, which are sponsored by local retailer Otto Group and phone operator Deutsche Telekom respectively, had backed Kaufda, which is sold to Germany-based media group Axel Springer.

In 2008, Coca-Cola, led by its Venturing and Emerging Brands (VEB) unit, purchased a minority stake in Honest Tea, an organic bottled tea company, and it has now bought the rest.

SalesForce is paying $276m in cash and $50m in its shares for Radian6. A further $10m in stock and $4m in cash will be issued to founders and will be subject to vesting conditions over two years.

Cephalon, a Nasdaq-listed drugs company, has agreed to buy Gemin X Pharmaceuticals, a biopharmaceutical company for cancer therapeutics, for $225m.

News Corp invested an undisclosed amount for a minority stake in Journalism Online in June last year and Jon Housman, president of digital journalism initiatives for the company, told news provider paidContent the company's investment "appreciated considerably" with the exit to RR Donnelley.

In an article by news provider VCCircle, Harshal Shah, chief executive of Reliance Ventures, said two private equity firms were picking up its stake in clothes maker Dhama Innovations.

McAfee, a US-based anti-virus software subsidiary of chipmaker Intel, has agreed to acquire local peer Sentrigo for an undisclosed amount.